Cargando…

DNA methylation and gene expression patterns in breast cancer progression from in situ carcinoma to invasive carcinoma

Detalles Bibliográficos
Autores principales:	Fleischer, Thomas, Edvardsen, Hege, Jovanovic, Jovana, Touleimat, Nizar, Børresen-Dale, Anne-Lise, Tost, Jörg, Kristensen, Vessela N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600744/ http://dx.doi.org/10.1186/1756-8935-6-S1-P18

Ejemplares similares

Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis
por: Fleischer, Thomas, et al.
Publicado: (2014)

Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumors
por: Klajic, Jovana, et al.
Publicado: (2013)

Differential DNA methylation analysis of breast cancer reveals the impact of immune signaling in radiation therapy
por: Halvorsen, Ann Rita, et al.
Publicado: (2014)

Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer
por: Muggerud, Aslaug Aa, et al.
Publicado: (2010)

Genome‐wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosis
por: Bjaanæs, Maria Moksnes, et al.
Publicado: (2015)

Genetic polymorphisms in the 5' flanking region of glutathione S-transferase P1 affect promoter methylation
por: Rønneberg, JA, et al.
Publicado: (2005)

DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival
por: Fleischer, Thomas, et al.
Publicado: (2016)

Allele-specific disparity in breast cancer
por: Kaveh, Fatemeh, et al.
Publicado: (2011)

DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancer
por: Johnson, Kevin C., et al.
Publicado: (2015)

Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumors
por: Aure, Miriam Ragle, et al.
Publicado: (2013)

Chromosome-wide pharmacogenetics: localisation and linkage disequilibrium of genes coding for ROS metabolism and signalling
por: Edvardsen, H, et al.
Publicado: (2005)

Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancer
por: Aure, Miriam Ragle, et al.
Publicado: (2021)

Linkage disequilibrium pattern of the ATM gene in breast cancer patients and controls; association of SNPs and haplotypes to radio-sensitivity and post-lumpectomy local recurrence
por: Edvardsen, Hege, et al.
Publicado: (2007)

Mutations for the people
por: Kristensen, Vessela, et al.
Publicado: (2010)

Genetic analysis of lobular carcinoma in situ and associated invasive lobular cancer
por: Yates, LR, et al.
Publicado: (2010)

ATM variants and cancer risk in breast cancer patients from Southern Finland
por: Tommiska, Johanna, et al.
Publicado: (2006)

A systematic comparison of copy number alterations in four types of female cancer
por: Kaveh, Fatemeh, et al.
Publicado: (2016)

Correction to: A systematic comparison of copy number alterations in four types of female cancer
por: Kaveh, Fatemeh, et al.
Publicado: (2018)

Comparison of methods for pharmacogenomics: SNaPshot, SNPstream UHT, Nanogen, and RFLP
por: Alnæs, GIG, et al.
Publicado: (2005)

Characterization of extracellular matrix composition in breast carcinoma
por: Bergamaschi, A, et al.
Publicado: (2005)

DNA methylation at enhancers identifies distinct breast cancer lineages
por: Fleischer, Thomas, et al.
Publicado: (2017)

Expression of wild-type and mutated TP53 in breast carcinomas
por: Baumbusch, LO, et al.
Publicado: (2005)

DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response
por: Dejeux, Emelyne, et al.
Publicado: (2010)

Promoter composition predicts gene classes in microarray expression analyses of breast cancer
por: Nordgard, SH, et al.
Publicado: (2005)

Discrepancies and challenge of ductal carcinoma in situ for health professionals
por: Kennedy, F, et al.
Publicado: (2008)

Subclassification and molecular characterization of early stage breast carcinomas using Applied Biosystems Human Genome Survey Microarrays
por: Wang, Y, et al.
Publicado: (2005)

Comparable cancer‐relevant mutation profiles in synchronous ductal carcinoma in situ and invasive breast cancer
por: Bergholtz, Helga, et al.
Publicado: (2020)

Predicting the presence of invasive carcinoma from the extent of mammographic malignant microcalcification and grade of ductal carcinoma in situ on core biopsy: results from a National Health Service Screening Programme
por: O'Flynn, EAM, et al.
Publicado: (2008)

In situ to invasive carcinoma transition: escape or release
por: Polyak, K
Publicado: (2003)

Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma
por: Bjørklund, Sunniva Stordal, et al.
Publicado: (2017)

GFRA3 promoter methylation may be associated with decreased postoperative survival in gastric cancer
por: Eftang, Lars Lohne, et al.
Publicado: (2016)

Screen-detected ductal carcinoma in situ - fine needle aspiration versus core biopsy
por: Lee, CM, et al.
Publicado: (2009)

Heterogeneous DNA Methylation Patterns in the GSTP1 Promoter Lead to Discordant Results between Assay Technologies and Impede Its Implementation as Epigenetic Biomarkers in Breast Cancer
por: Grenaker Alnaes, Grethe I., et al.
Publicado: (2015)

Ductal carcinoma in situ (DCIS): the role of prognostic indicators in informing treatment and reducing local recurrence
por: Clements, K, et al.
Publicado: (2004)

Ductal carcinoma in situ (DCIS) down under: patterns of diagnosis and treatment in BreastScreen Victoria
por: Wilkinson, J
Publicado: (2004)

Expression of c-met gene in invasive ductal carcinomas
por: Park, CH, et al.
Publicado: (2005)

De novo expression of α(v)β(6 )integrin by myoepithelial cells in ductal carcinoma in situ may be an important marker of disease progression
por: Allen, M, et al.
Publicado: (2008)

Overrepresentation of transcription factor families in the genesets underlying breast cancer subtypes
por: Joshi, Himanshu, et al.
Publicado: (2012)

Assessment of angiogenesis in the hyperplasia preinvasive, invasive breast carcinoma sequence
por: Bluff, JE, et al.
Publicado: (2008)

Can mammographic features predict invasive carcinoma at screening assessment?
por: Forester, ND, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_kdr80oq9vagjsmm2583do7o073